API | Diatrizoate

Diatrizoate (gastrografin) Report issue

Small molecule Experimental

AACT Drug Central PubChem

Active Ingredient History

NOW

Diatrizoate, also known as amidotrizoate, is a contrast agent used during X-ray imaging. This includes visualizing veins, the urinary system, spleen, and joints, as well as computer tomography. It is given by mouth, injection into a vein, injection into the bladder, through a nasogastric tube, or rectally. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

gastrografin | urografin

Organizations (14)

Research & Development (14)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (10)

Approved Indications (1)

Diagnostic Imaging

Experimental Indications - Clinical Trial Phases 1-4 (9)

Congenital Abnormalities (Phase 4)

Fecal Impaction (Phase 2)

Gastroschisis (Phase 4)

Infant, Very Low Birth Weight (Phase 4)

Intestinal Diseases (Phase 4)

Intestinal Neoplasms (Phase 4)

Meconium Ileus (Phase 4)

Postoperative Complications (Phase 4)

Urethral Diseases (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial Organizations: 14

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue